Acurx Pharmaceuticals, Inc. Share Price
NASDAQ: ACXP | Micro CapAcurx Pharmaceuticals, Inc. Stock Performance
Open $1.49 | Prev. Close $1.46 | Circuit Range N/A |
Day Range $1.49 - $1.53 | Year Range $1.35 - $8.30 | Volume 500 |
Average Traded $1.50 |
Acurx Pharmaceuticals, Inc. Share Price Today
As of 7 August 2026, Acurx Pharmaceuticals, Inc.'s share price is $1.53. The stock opened at $1.49, compared to its previous close of $1.46. During today's trading session, Acurx Pharmaceuticals, Inc.'s share price traded between $1.49 and $1.53, with an average price of $1.51. Over the past 52 weeks, the stock has recorded a high of $8.30 and a low of $1.35. In terms of performance, Acurx Pharmaceuticals, Inc.'s share price has risen by 2.68% over the last six months and is down 65.23% on a year-on-year basis.
Acurx Pharmaceuticals, Inc. Share Price Chart
Acurx Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Market Cap $2.29M | PE Ratio (TTM) -0.29 | Dividend Yield N/A |
EPS (TTM) $-5.32 | Revenue (TTM) N/A | Return On Equity (TTM) -151.21% |
Profit Margin N/A | Debt to Equity 0.46 | Quarterly Earnings Growth YoY 29.37% |
Acurx Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Acurx Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Acurx Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.42 | $1.53 | +9.68% |
Jul 2026 | $1.53 | $1.40 | -9.71% |
Jun 2026 | $1.93 | $1.54 | -21.57% |
May 2026 | $2.18 | $1.97 | -8.80% |
Apr 2026 | $3.73 | $2.16 | -41.30% |
Mar 2026 | $1.46 | $3.68 | +146.98% |
Feb 2026 | $2.44 | $1.49 | -37.13% |
Jan 2026 | $2.75 | $2.37 | -13.82% |
Dec 2025 | $3.68 | $2.75 | -28.85% |
Nov 2025 | $4.92 | $3.87 | -23.47% |
Oct 2025 | $4.61 | $5.05 | +23.77% |
Sep 2025 | $4.49 | $4.08 | -7.27% |
ACXP Share Price FAQs
What is Acurx Pharmaceuticals, Inc. share price today?
What is the 52 week high and 52 week low of Acurx Pharmaceuticals, Inc. stock?
What is ACXP's market capitalisation today?
What is ACXP's net income for the last quarter?
What is the 5 year returns of ACXP?
What is the high & low stock price of ACXP today?
Can I buy ACXP shares in India?